Can German pot succeed in a crowded medicinal marijuana market? | Business| Economy and finance news from a German perspective | DWPosted by On


Commercial hemp growers in Neumünster, Germany, were recently jubilant about their first legal marijuana harvest. Owned and operated by Canadian cannabis company Aphria RX, the plantation has grown a batch of 50 kilograms (110 pounds). The company told DW in a statement that they aim to expand production to “about a ton in the course of the next 12 months.”

Security precautions are tight at Aphria RX’s indoor growing facility, with the plants grown behind tall concrete walls with barbed wire. That is because the use of  medical marijuana in Germany still falls under sweeping narcotics laws overseen by the Institute for Drugs and Medical Devices (BfArM).

Now the first supplies from Neumünster have been sent to pharmacies all over Germany and will be distributed “by prescription only” to patients suffering mainly from pain, spasticity or anorexia.

The use of cannabis for medicinal purposes was legalized in Germany in 2017. The BfArM institute chose three cultivators in 2019 to ensure a national supply — two of which, Aurora Cannabis and Aphria RX, are based in Canada, while the other is Germany-based startup Demecan.

A picture showing Aphria's indoor cultivation facility in Neumünster, fenced off with barbed wire

Security requirements for cannabis cultivation in Germany are high forcing producers to grow the plant behind barbed wire

So far, however, only Aphria RX has come onto the German market, with the other two contractors remaining vague about production starts in statements to DW. Aurora said it was currently importing cannabis from Canada, which…

Original Author Link click here to read complete story..

Commercial hemp growers in Neumünster, Germany, were recently jubilant about their first legal marijuana harvest. Owned and operated by Canadian cannabis company Aphria RX, the plantation has grown a batch of 50 kilograms (110 pounds). The company told DW in a statement that they aim to expand production to “about a ton in the course of the next 12 months.”

Security precautions are tight at Aphria RX’s indoor growing facility, with the plants grown behind tall concrete walls with barbed wire. That is because the use of  medical marijuana in Germany still falls under sweeping narcotics laws overseen by the Institute for Drugs and Medical Devices (BfArM).

Now the first supplies from Neumünster have been sent to pharmacies all over Germany and will be distributed “by prescription only” to patients suffering mainly from pain, spasticity or anorexia.

The use of cannabis for medicinal purposes was legalized in Germany in 2017. The BfArM institute chose three cultivators in 2019 to ensure a national supply — two of which, Aurora Cannabis and Aphria RX, are based in Canada, while the other is Germany-based startup Demecan.

A picture showing Aphria's indoor cultivation facility in Neumünster, fenced off with barbed wire

Security requirements for cannabis cultivation in Germany are high forcing producers to grow the plant behind barbed wire

So far, however, only Aphria RX has come onto the German market, with the other two contractors remaining vague about production starts in statements to DW. Aurora said it was currently importing cannabis from Canada, which…



Source link

News

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.